Please provide your email address to receive an email when new articles are posted on . A real-world efficacy study of EyePoint Pharmaceuticals’ Yutiq fluocinolone implant in eyes with chronic ...

Please provide your email address to receive an email when new articles are posted on . A validated prognostic tool using common clinical markers could help clinicians evaluate patients with juvenile ...

SEATTLE — Uveitis expert Nisha Acharya, MD, shared three clinical pearls on the condition at the American Society of Retina Specialists (ASRS) 2023 Annual Meeting. "Chronic or recurrent uveitis ...

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™. Highlighting the latest ophthalmology-related news reported across MJH Life Sciences ™. Leveraging Autoantibodies ...

Early-onset, chronic nonanterior uveitis in children increases the risk of ocular complications, with 44.3% experiencing issues like cataracts and macular edema. Persistent chronic uveitis is a ...

WASHINGTON, DC—Use of weekly adalimumab in children with juvenile idiopathic arthritis (JIA), pediatric chronic uveitis, and other childhood rheumatic diseases is safe and effective, with 90% having a ...

Patients with psoriasis, uveitis, or colitis who present with undiagnosed chronic back pain should be referred to a rheumatologist for the assessment of axial spondyloarthritis (axSpA), with MRI being ...

YUTIQ addresses a significant unmet need in the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. The uveitis treatment market is projected to grow steadily, ...

Yutiq is supplied as a 0.18mg single-dose, preloaded applicator with a 25-gauge needle. EyePoint announced the launch of Yutiq (fluocinolone acetonide intravitreal implant) for the treatment of ...

Uveitis severity is often worse, bilateral, and prolonged among individuals with chronic plaque psoriasis. Uveitis severity is worse and tends to be bilateral and prolonged in individuals with chronic ...